We hope you find what you’re looking for. You can email us if you need additional help.
Karina is Optimi’s Director of Quality and Commercial Strategies focussing on commercial scale up, GACP and GMP processes.
Laura is responsible for product growth development and sales of Optimi Life’s nutraceutical supplements.
Preston is an award-winning R&D chemist and business professional with over 25 years academic and industrial experience in development and commercialization of new products.
Scott is Optimi Health’s Cultivation Manager, heading the development and implementation of Good Agricultural and Collection Practices (GACP) for Optimi’s botanical drug development program.
Tara is a highly accomplished Sales & Marketing Director with over 15 years of experience and a track record of building brands from the ground up.
Regulator Filings
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th